DiviDrip · AAPG

AAPG — Ascentage Pharma Group Internat

AAPG is Ascentage Pharma Group Internat (Healthcare) — a non-dividend-paying stock. Trading at $16.81. Market cap: $1.52B. Capital Quality Rank: 58/100 — Above average.

Stock snapshot

Price$16.81
Market cap$1.52B
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)58 / 100 · Above average
Altman Z-score zoneSafe

About AAPG

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Listed2025Employees767SectorHealthcareWebsiteascentage.cn

Frequently asked

What is AAPG's current stock price?

AAPG (Ascentage Pharma Group Internat) is currently trading at $16.81.

Does AAPG pay a dividend?

AAPG (Ascentage Pharma Group Internat) does not currently pay a regular dividend.

What is AAPG's Capital Quality Rank?

AAPG has a Capital Quality Rank of 58/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AAPG in DiviDrip

Add AAPG to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-02. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow